NCT05943288Completed
Safety and Efficacy of the Olympus CADe System in Real-time Colonoscopy
Safety and Efficacy of the Olympus Endoscopy Computer-Aided Detection (CADe) System in Detection of Colorectal Neoplasia's During Real-time Colonoscopy: A European Prospective, Multicenter, Randomized Controlled Trial (EuroCADe)
Source: ClinicalTrials.gov · Last updated 18 Mar 2025
Brief summary (registry, in English)
This is a prospective, multicenter, randomized Trial to assess the safety and efficacy of the Olympus Endoscopy Computer-Aided Detection (CADe) system, OIP-1, in the detection of colorectal neoplasia's during real-time colonoscopy. The aim of this system is to improve physician performance in the detection of potential mucosal abnormalities during colonoscopy performed for primary Colorectal Cancer screening or postpolypectomy surveillance.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 850 (actual)
- First submitted
- 7 Jun 2023
- Start date
- Apr 2023
- Primary completion date
- Jul 2024
- Lead sponsor
- Olympus Europe SE & Co. KG
- Diseases
- Colorectal cancer
- NCT number
- NCT05943288
What you commit to
- Study type: Observational
- Participants enrolled: 850
- From Apr 2023 to the primary completion date, Jul 2024
- 6 sites in 4 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior failed colonoscopy
- multiple historic prior failed colonoscopy due to poor bowel preparation OR
- a single prior failed colonoscopy due to reasons other than poor bowel preparation
- Concurrent participation in another competing clinical study
Other illness
- History of CRC or inflammatory bowel disease or polyposis syndrome / familial adenomatous polyposis coli (FAP)
- History of radio- and/or chemotherapy
Other
- Lack of informed written consent
- Biopsy/anesthesia/sedation contraindications
Who the study is looking for
- Signed informed consent
- 45-80 years
- Undergoing colonoscopy for primary CRC screening or postpolypectomy surveillance
Age in the registry: 45 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (6)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| ZU Leuven Coordinator of this site? Confirm its status | Leuven | Belgium | Unknown status |
| Evangelisches Krankenhaus Düsseldorf Coordinator of this site? Confirm its status | Düsseldorf | Germany | Unknown status |
| Universitätsklinikum Ulm Coordinator of this site? Confirm its status | Ulm | Germany | Unknown status |
| Fundación Biomédica Galicia Sur Coordinator of this site? Confirm its status | Pontevedra | Spain | Unknown status |
| Hospital Universitari i Politécnic La Fe Coordinator of this site? Confirm its status | Valencia | Spain | Unknown status |
| Linköping Universitetssjukhus Coordinator of this site? Confirm its status | Linköping | Sweden | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.